AdvanDX finds $15M in third VC round

France's BioMerieux has signed on as an investor for AdvanDX, a diagnostics company based in Woburn, MA, contributing to a $15 million Series C round for the company. The money is earmarked for R&D and marketing costs. AdvanDX is marketing its PNA FISH test, a rapid diagnostic for blood infections.

- here's the release on the round